Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02268370
Title Treatment-free Remission Accomplished With Dasatinib in Patients With CML (TRAD)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications
Therapies
Age Groups: adult
Covered Countries CAN


No variant requirements are available.